Abstract Wild-type KRAS ( WT ) amplification has been shown to be a secondary means of activation in cancer and associated with poor survival. Nevertheless, the precise role overexpression lung progression is largely unexplored. Here, we identify characterize KRAS-responsive lncRNA, KIMAT1 (ENSG00000228709) show that it correlates levels both cell lines specimens. Mechanistically, MYC target dr...